Perfusion Parameters and Outcome During a Standardized Deresuscitation Strategy with Net Ultrafiltration: a Retrospective Cohort Study.
Launched by HOSPICES CIVILS DE LYON · Mar 21, 2025
Trial Information
Current as of May 09, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age ≥ 18 years old
- • Acute kidney injury requiring continuous renal replacement therapy
- • Standardized deresuscitation following a routine care protocol
- Exclusion Criteria:
- • Chronic hemodialysis
- • Advanced directives to withhold or withdraw life-sustaining treatment,
- • Patient's opposition to the use of his/her personal health data
About Hospices Civils De Lyon
Hospices Civils de Lyon (HCL) is a leading public health institution in France, dedicated to providing high-quality healthcare and advancing medical research. With a rich history dating back to the 18th century, HCL encompasses multiple hospitals and offers a diverse range of services across various medical specialties. The institution is committed to fostering innovative clinical trials that aim to enhance patient care and improve therapeutic outcomes. By collaborating with academic and industry partners, HCL plays a pivotal role in the development of new treatments and the advancement of medical knowledge, ensuring that research efforts are aligned with the highest ethical standards and patient safety protocols.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
France, Bron, France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported